A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0973 Following Single Oral Dose Administration in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2016
Price : $35 *
At a glance
- Drugs Cobimetinib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Genentech
- 23 Oct 2013 Results presented at the 25th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
- 27 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Nov 2012 New trial record